ES2091186T3 - Procedimiento para obtener antigenos protectores contra infecciones y procesos toxicos de bordetella. - Google Patents

Procedimiento para obtener antigenos protectores contra infecciones y procesos toxicos de bordetella.

Info

Publication number
ES2091186T3
ES2091186T3 ES88400949T ES88400949T ES2091186T3 ES 2091186 T3 ES2091186 T3 ES 2091186T3 ES 88400949 T ES88400949 T ES 88400949T ES 88400949 T ES88400949 T ES 88400949T ES 2091186 T3 ES2091186 T3 ES 2091186T3
Authority
ES
Spain
Prior art keywords
bordetella
procedure
against infections
protective antigens
antigens against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88400949T
Other languages
English (en)
Inventor
Murielle Rocancourt
Colette Brezin
Jean-Luc Boucaud
Marek Szatanik
Jean-Michel Alonso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut Pasteur de Lille
Application granted granted Critical
Publication of ES2091186T3 publication Critical patent/ES2091186T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

EL METODO DEL INVENTO ESTA CARACTERIZADO POR EL USO PARA OBTENER PREPARADOS ACLASE DE ADILINATO DE B. PARAPERTUSSIS O VARIANTES.
ES88400949T 1988-04-19 1988-04-19 Procedimiento para obtener antigenos protectores contra infecciones y procesos toxicos de bordetella. Expired - Lifetime ES2091186T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88400949A EP0338169B1 (en) 1988-04-19 1988-04-19 Method for obtaining protective antigens against bordetella infections and toxic processes

Publications (1)

Publication Number Publication Date
ES2091186T3 true ES2091186T3 (es) 1996-11-01

Family

ID=8200381

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88400949T Expired - Lifetime ES2091186T3 (es) 1988-04-19 1988-04-19 Procedimiento para obtener antigenos protectores contra infecciones y procesos toxicos de bordetella.

Country Status (10)

Country Link
US (1) US5595901A (es)
EP (2) EP0691348A1 (es)
JP (1) JP2999480B2 (es)
AT (1) ATE140729T1 (es)
CA (1) CA1341332C (es)
DE (1) DE3855442T2 (es)
DK (1) DK175663B1 (es)
ES (1) ES2091186T3 (es)
GR (1) GR3021331T3 (es)
PT (1) PT90310B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (fr) * 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
US6030625A (en) * 1994-12-15 2000-02-29 Institut Pasteur Bordetella pertussis and Bordetella parapertussis strains
FR2736064B1 (fr) 1995-06-30 1997-09-05 Pasteur Institut Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella
WO1999057120A1 (en) 1998-05-04 1999-11-11 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
AU2001271908A1 (en) 2000-07-07 2002-01-21 Neotherapeutics, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
US7462472B2 (en) * 2001-11-02 2008-12-09 The University Of Chicago Methods and compositions relating to anthrax pathogenesis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
FR2606789B1 (fr) * 1986-11-17 1991-05-31 Pasteur Institut Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques
EP0338170A1 (en) * 1988-04-19 1989-10-25 Institut Pasteur Immunoprotective antigenic protein against pathogenic bacteria
US5312749A (en) * 1992-05-12 1994-05-17 The United States Of America As Represented By The Secretary Of Agriculture Industrial alkaline protease from shipworm bacterium

Also Published As

Publication number Publication date
DK175663B1 (da) 2005-01-10
PT90310A (pt) 1989-11-10
US5595901A (en) 1997-01-21
ATE140729T1 (de) 1996-08-15
CA1341332C (en) 2002-01-08
DE3855442T2 (de) 1997-03-06
JP2999480B2 (ja) 2000-01-17
EP0691348A1 (en) 1996-01-10
GR3021331T3 (en) 1997-01-31
DE3855442D1 (de) 1996-08-29
DK190989D0 (da) 1989-04-19
EP0338169A1 (en) 1989-10-25
DK190989A (da) 1989-10-20
PT90310B (pt) 1994-09-30
JPH02131432A (ja) 1990-05-21
EP0338169B1 (en) 1996-07-24

Similar Documents

Publication Publication Date Title
ES2091186T3 (es) Procedimiento para obtener antigenos protectores contra infecciones y procesos toxicos de bordetella.
ES2081857T3 (es) Nuevos inhibidores de alpha-glucosidasa.
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
DK0428038T3 (da) Transdermal administration af 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
ES2186667T3 (es) Analogos de nucleosidos de 1,3-oxatiolano.
DK483285A (da) Farmaceutisk praeparat og anvendelsen af samme
ES2126966T3 (es) Proceso para la impregnacion hidrofuga de yeso.
MX9305054A (es) Usos novedosos de il-4 y/o il-10, y anticuerpos contra los mismos.
TR199801141T2 (xx) T�bbi splint (k�r�k deste�i), s�z konusu splint i�in metal tabaka ve s�zkonusu splint'in kullan�m�.
MX9203320A (es) Composicion antialergica que contiene compuestos biciclicos switterionicos.
ES2191075T3 (es) 8-arilalquil- y 8-arilheteroalquil-5,11-dihidro-6h-dipirido-(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infecciones por hiv.
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
ES2087160T3 (es) Composiciones y procedimiento para el tratamiento de trastornos dolorosos, inflamatorios o alergicos.
MX24839A (es) 3-arilcarbonil-1-aminoalquilo-1h-indoles, proceso para su preparacion y composicion farmaceutica quelos contiene.
FI951511A0 (fi) IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon
ES2125331T3 (es) Agente terapeutico obtenido a partir de micobacterium vaccae y su utilizacion para luchar contra la infeccion vih con sida.
FI920356A0 (fi) En biologisk preparation samt dess anvaendning.
DK0379933T3 (da) Superficielt behandlingssystem med indhold af et antineoplastisk aktivstof, især 5-fluoruracil
DK0588796T3 (da) Sampanginderivater til anvendelse som antifungiske og antimykobakterielle midler
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
CL2004001291A1 (es) Composicion farmaceutica que comprende compuestos carbociclicos y heterociclicos; y su uso para el tratamiento o profilaxis de la infeccion por influenza.
FR2632525B1 (fr) Application therapeutique de la myeloperoxydase humaine
DE69114707D1 (de) Neue alpha-glukosidaseinhibitoren.
MX164619B (es) Composicion para el tratamiento de lesiones cutaneas
DE3888391T2 (de) Substituierte Silylalkylenamine.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 338169

Country of ref document: ES